Yu CC - Search Results

1

CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.

Huang SP, Yu CC, Liu CC, Wu TT, Huang CH, Wu MT. Huang SP, et al. Among authors: yu cc. Urol Int. 2008;81(1):36-40. doi: 10.1159/000137638. Epub 2008 Jul 16. Urol Int. 2008. PMID: 18645269

2

Secondary signet-ring cell carcinoma of the prostate.

Lin JT, Yu CC, Lee JH, Wu TT; Division of Urology, Department of Surgery, Veterans General Hospital-Kaoshiung and National Yang-Ming University School of Medicine, Taipei, Taiwan, Republic of China. Lin JT, et al. Among authors: yu cc. J Urol. 2002 Oct;168(4 Pt 1):1492. doi: 10.1016/S0022-5347(05)64484-9. J Urol. 2002. PMID: 12352428 No abstract available.

3

Androgen receptor gene polymorphism and prostate cancer in Taiwan.

Huang SP, Chou YH, Chang WS, Wu MT, Yu CC, Wu T, Lee YH, Huang JK, Wu WJ, Huang CH. Huang SP, et al. Among authors: yu cc. J Formos Med Assoc. 2003 Oct;102(10):680-6. J Formos Med Assoc. 2003. PMID: 14691592

4

Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.

Huang SP, Chou YH, Wayne Chang WS, Wu MT, Chen YY, Yu CC, Wu TT, Lee YH, Huang JK, Wu WJ, Huang CH. Huang SP, et al. Among authors: yu cc. Cancer Lett. 2004 Apr 15;207(1):69-77. doi: 10.1016/j.canlet.2003.12.006. Cancer Lett. 2004. PMID: 15050735

5

p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.

Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ, Yu CC, Wu TT, Lee YH, Huang JK, Huang CH. Huang SP, et al. Among authors: yu cc. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2217-24. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598783

6

Correlation of p53 protein accumulation and Bcl-2 overexpression with histopathological features in prostatic cancer.

Lin JT, Wang JS, Jiann BP, Yu CC, Tsai JY, Huang JK, Wu TT. Lin JT, et al. Among authors: yu cc. J Formos Med Assoc. 2005 Nov;104(11):864-7. J Formos Med Assoc. 2005. PMID: 16496070

7

Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.

Huang SP, Huang CY, Wu WJ, Pu YS, Chen J, Chen YY, Yu CC, Wu TT, Wang JS, Lee YH, Huang JK, Huang CH, Wu MT. Huang SP, et al. Among authors: yu cc. Int J Cancer. 2006 Oct 15;119(8):1902-7. doi: 10.1002/ijc.22053. Int J Cancer. 2006. PMID: 16708371

8

Role of p21(WAF1) and p27(KIP1) in predicting biochemical recurrence for organ-confined prostate adenocarcinoma.

Wu TT, Wang JS, Jiaan BP, Yu CC, Tsai JY, Lin JT, Huang JK. Wu TT, et al. Among authors: yu cc. J Chin Med Assoc. 2007 Jan;70(1):11-5. doi: 10.1016/S1726-4901(09)70294-1. J Chin Med Assoc. 2007. PMID: 17276927 Free article.

9

Expression of vascular endothelial growth factor in Taiwanese benign and malignant prostate tissues.

Wu TT, Wang JS, Jiann BP, Yu CC, Tsai JY, Lin JT, Huang JK. Wu TT, et al. Among authors: yu cc. J Chin Med Assoc. 2007 Sep;70(9):380-4. doi: 10.1016/S1726-4901(08)70024-8. J Chin Med Assoc. 2007. PMID: 17908652 Free article.

10

Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.

Huang SP, Huang CY, Wang JS, Liu CC, Pu YS, Yu HJ, Yu CC, Wu TT, Huang CH, Wu WJ, Chou YH, Wu MT. Huang SP, et al. Among authors: yu hj, yu cc. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6632-8. doi: 10.1158/1078-0432.CCR-07-1437. Clin Cancer Res. 2007. PMID: 18006764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,185 results

Search Page

Filters